Risk of Death in COVID-19 Patients with Comorbidity of Chronic Kidney Disease: Meta Analysis

Authors

  • Isna Nur Rohmah Masters Program in Public Health, Universitas Sebelas Maret
  • Didik Gunawan Tamtomo Faculty of Medicine, Universitas Sebelas Maret
  • Bhisma Murti Masters Program in Public Health, Universitas Sebelas Maret

Abstract

Background: Coronavirus disease 2019 or known as COVID-19 was a disease caused by severe acute respiratory coronavirus 2 (SARS-CoV-2). There are seven comorbidities that experience the most severity and death when infected with COVID-19, namely hypertension, diabetes mellitus, cardiovascular disease, chronic obstructive pulmonary disease, chronic kidney disease, cerebrovascular disease, and cancer. This study aimed to estimate the magnitude of the risk of death in COVID-19 patients with comorbid chronic kidney disease, with a meta-analysis of primary studies conducted by previous authors.

Subjects and Method: This study was a systematic review and meta-analysis with the following PICO, population: COVID-19 patients. Intervention: comorbid chronic kidney disease. Compa

References

Almazeedi S, Al-Youha S, Jamal MH, Al-Haddad M, Al-Muhaini A, Al-Ghimlas, Al-Sabbah S (2020). Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait. EClinicalMedicine. 2 (100448) 1-9. doi:

1016/j.eclinm.2020.100448.

Bourgonje AR, Abdulle AE, Timens W, Hillebrands J, Navis GJ, Gordijn SJ, Bolling MC (2020). Angiotensin converting enzyme-2 (ACE2), SARS-CoV-2 and pathophysiology of coronavirus disease 2019 (COVID-19). J. Pathol. 251(3):228-248. doi: 10.1002/path.5471.

CASP (2018). Critical appraisal skills programme cohort study checklist. Retrieved from https://casp-uk.net/wpcontent/uploads/2018/01/CASP-Cohort-Study-Checklist_2018.pdf.

Chen TK, Knicely DH, Grams ME (2019). Chronic kidney disease diagnosis and management. JAMA. 322 (13): 1294-1304. doi: 10.1001/jama.2019.14745.

Chen Y, Guo Y, Pan Y, Zhao ZJ (2020). Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 525(1): 135-140. doi: 10.1016/j.bbrc.2020.02.071.

Chin HJ, Song YR, Lee JJ, Lee SB, Kim KW, Na KY, Kim S et al. (2008). Moderately decreased renal function negatively affects the health related quality of life among the elderly Korean population: a population based study. Nephrol Dial Transplant.

(9): 2810-2817. doi: 10.1093/ndt/gfn132.

Cuker A, Flora P (2021). COVID-19: Hypercoagulability. Retrieved from https://www.uptodate.com/contents/covid-19-hypercoagulability.

Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J, Wang H et al. (2004). Organ distribution of severe acute respiretory syndrome (SARS) associated coronavirus (SARS?CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J

Pathol. 203 (2): 622-630. doi: 10.1002/path.1560.

Etgen T, Chonchol M, F

Fang X, Li S, Yu H, Wang P, Zhang Y, Chen Z, Li Y, et al. (2020). Epidemiological, comorbidity factors with severity and prognosis of COVID-19: A systematic review and meta-analysis. Aging. 12 (13): 12493-12503. doi: 10.18632/aging.103579.

Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJL, Mann JF, Matsushita K et al. (2013). Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 382 (9889): 339-352. doi: 10.1016/S01406736(13)605954.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L et al. (2020). Clinical characteristics of coronavirus disease 2019 in china. New Eng J Med. 382 (18): 1708-1720. doi: 10.1056/NEJMoa2002032.

Li X, Geng M, Peng Y, Meng L, Lu S (2020). Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 10 (2): 102-108. doi: 10.1016/j.jpha.2020.03.001.

Matsushita K, Velde MVD, Astor BC, Woodward M, Levey AS, Jong PED, Coresh J et al. (2010). Association of estimated glomerular filtration rate and albuminuria with all cause and cardiovascular mortality: a collaborative meta-analysis of general populartion

cohorts. Lancet. 375(9731): 2073-2081. doi: 10.1016/S0140 6736(10)606745.

NIH (2017). Chronic kidney disease (CKD). National institutes of health. Retrieved from https://www.niddk.nih.gov/health-information/kidney-disease-/chronic-kidneydisease-ckd/what-is-chronic-kidney-disease.

O

Rocha S, Valente MJ, Coimbra S, Catarino C, Rocha-Pereira P, Oliveira JG, Madureira J et al. (2021). Interleukin 6 (rs1800795) and pentraxin 3 (rs2305619) polymorphisms association with inflammation and all-cause mortality in end-stage-renal disease

patients on dialysis. Sci Rep. 11: 14768. doi: 10.1038/s41598-021-940-75-x.

Ruan Q, Yang K, Wang W, Jiang L, Song J (2020). Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 46: 846-848. doi: 10.1007/s00134-020-05991-x.

Tsai PH, Lai W, Lin Y, Luo Y, Lin Y, Chen H, Chen Y et al. (2021). Clinical manifestation and disease progresssion in COVID-19 infection. J Chin Med Assoc. 84(1): 3-8. doi: 10.1097/JCMA.0000000000000463.

WHO (2021). WHO coronavirus (COVID-19) Dashboard. World Health Organization. Retrieved from https://covid-19.who.int/.

Willim HA, Hardigaloeh AT, Supit AI, Handriyani (2020). Koagulopati pada Coronavirus Disease-2019 (COVID-19) (Coagulopathy in Coronavirus Disease-2019 (COVID-19): Tinjauan Pustaka. Intisari Sains Medis. 11 (3): 749-756.doi: 10.15562/ism.v11i3.766.

Wu Z, McGoogan JM (2020). Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA. 323(13): 1239-1242. doi: 10.1001/jama.2020.2648.

Zou X, Chen K, Zou J, Han P, Hao J, Han Z (2020). Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 12: 1-8. doi: 10.1007/s11684-020-07-54-0.

Downloads

Published
2021-12-07

Issue
Vol. 6 No. 3 (2021)

Section
flow-chart-line Articles

How to Cite
Rohmah, I. N., Tamtomo, D. G., & Murti, B. (2021). Risk of Death in COVID-19 Patients with Comorbidity of Chronic Kidney Disease: Meta Analysis. Journal of Epidemiology and Public Health, 6(3), 268–280. Retrieved from https://jepublichealth.com/index.php/jepublichealth/article/view/420

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >>